---
cssClass:
- wide
tags:
  - ðŸ§ª
---

# `Title:` [[GLP1]]
--- 

- What led me here: [[Proteins]] [[Diabetes]]

Inlinks
```dataview 
list from [[#this.file.name]] and !outgoing([[# this.file.name]]) 
```

---

### GLP1 Protein (Glucagon-Like Peptide-1)

**GLP1** is an incretin hormone that plays a crucial role in glucose metabolism, insulin secretion, and appetite regulation.

#### Overview

GLP1 is derived from the proglucagon gene and is produced by L-cells in the small intestine. It acts primarily on the pancreas.

#### Structure

- **Amino Acids**: A 30-amino acid peptide hormone.
- **Receptor**: Binds to the GLP1 receptor (GLP1R), a G protein-coupled receptor.

#### Function

1. **Insulin Secretion**: Enhances glucose-dependent insulin secretion from pancreatic beta cells.
2. **Glucagon Suppression**: Inhibits glucagon secretion, reducing hepatic glucose production.
3. **Gastric Emptying**: Slows down gastric emptying, contributing to satiety.
4. **Appetite Control**: Reduces appetite and food intake through central mechanisms.

#### Therapeutic Use

- **Type 2 Diabetes**: GLP1 receptor agonists are used to enhance insulin secretion and lower blood sugar levels.
- **Obesity**: Used as a weight loss agent due to its effects on satiety.
- **Cardiovascular Benefits**: Some studies show potential protective effects on the cardiovascular system.

#### Pharmacological Agents

- **Exenatide**: A synthetic version of exendin-4, which is similar to human GLP1.
- **Liraglutide**: A GLP1 analog with modifications for longer activity.

#### Metabolism

- **DPP-4 Degradation**: Rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4).

#### Research Directions

- **Combination Therapies**: Combined with other antidiabetic agents for synergistic effects.
- **Long-Acting Analogues**: Development of newer analogs for extended action.

#### See Also

- [Insulin](https://en.wikipedia.org/wiki/Insulin)
- [Type 2 Diabetes](https://en.wikipedia.org/wiki/Type_2_diabetes)

---

GLP1 is a multifunctional peptide hormone with a profound influence on glucose metabolism and energy homeostasis. Its ability to enhance insulin secretion and induce weight loss has led to the development of GLP1-based therapies for type 2 diabetes and obesity. These therapies represent a significant advancement in the treatment of metabolic disorders, with ongoing research aiming to optimize their efficacy and expand their applications.